CRTX — CRISM Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- £4.40m
- £2.53m
Annual balance sheet for CRISM Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Cash | |||||
| Cash and Short Term Investments | 0.3 | 2.04 | 4.94 | 2.88 | 3.44 |
| Net Total Receivables | 0.024 | 0.004 | 0.081 | 0 | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.667 | 2.31 | 5.02 | 2.93 | 3.76 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 20.7 | 17.5 | 0 | — | — |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 21.3 | 23.7 | 23.1 | 23.8 | 3.76 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.728 | 0.668 | 0.715 | 0.616 | 0.52 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.851 | 0.771 | 0.833 | 0.761 | 0.52 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 20.5 | 22.9 | 22.3 | 23 | 3.24 |
| Total Liabilities & Shareholders' Equity | 21.3 | 23.7 | 23.1 | 23.8 | 3.76 |
| Total Common Shares Outstanding |